What does DR. ANNKE NELDE - GERIATRIE do?

DR. ANNKE NELDE - GERIATRIE is a specialist medical practice in Beauvechain. Private Limited, started on 9 September 2014, 1 establishment.

What is the address of DR. ANNKE NELDE - GERIATRIE?

The registered office of DR. ANNKE NELDE - GERIATRIE is located at Rue Delherse,H.-M. 20, 1320 Beauvechain.

Is DR. ANNKE NELDE - GERIATRIE still active?

Yes. According to the CBE (19 September 2026) DR. ANNKE NELDE - GERIATRIE is active, legal situation “Normale toestand”, started on 9 September 2014.

Is DR. ANNKE NELDE - GERIATRIE registered on Peppol?

Yes, DR. ANNKE NELDE - GERIATRIE is registered on the Peppol network with ID 0208:0562727484.

What is the enterprise number of DR. ANNKE NELDE - GERIATRIE?

The enterprise number of DR. ANNKE NELDE - GERIATRIE is BE0562727484.

When was DR. ANNKE NELDE - GERIATRIE founded?

DR. ANNKE NELDE - GERIATRIE was founded on 9 September 2014.

Who are the directors of DR. ANNKE NELDE - GERIATRIE?

According to the 2025 annual accounts, the directors of DR. ANNKE NELDE - GERIATRIE are: Sven Delsupehe, Annke Nelde.

Is DR. ANNKE NELDE - GERIATRIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 September 2014; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. ANNKE NELDE - GERIATRIE make in 2025?

DR. ANNKE NELDE - GERIATRIE posted a profit after taxes of € 117,236 in financial year 2025.

What is the revenue of DR. ANNKE NELDE - GERIATRIE?

As a small company, DR. ANNKE NELDE - GERIATRIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 168,911.

DR. ANNKE NELDE - GERIATRIE (Private Limited)

Dossier DR. ANNKE NELDE - GERIATRIE, printed on 19 September 2026 from databakkes.be/en/0562727484/dr-annke-nelde-geriatrie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. ANNKE NELDE - GERIATRIE from Beauvechain, company number BE0562727484, closed financial year 2025 with a result of € 117,236 after tax. For that financial year DR. ANNKE NELDE - GERIATRIE recorded a gross margin of € 168,911 and equity of € 696,709. Compared with financial year 2024, the result moved from € 92,580 to € 117,236. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.

What it is worth Growing

€ 696,709

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 117,236

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 233,535

▲ 26% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 68,421 paid out

58 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 337

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 320

▼ 39% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,299

▲ 143% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 183,108 Gross margin 2022: € 183,108 First fiscal year in the series	€ 177,332 Gross margin 2023: € 177,332 ▼ 3% vs 2022 (€ 183,108) Unfavourable step	€ 162,165 Gross margin 2024: € 162,165 ▼ 9% vs 2023 (€ 177,332) Unfavourable step	€ 168,911 Gross margin 2025: € 168,911 ▲ 4% vs 2024 (€ 162,165) Favourable step	▲ 4%
Profit after taxes	€ 125,052 Profit after taxes 2022: € 125,052 First fiscal year in the series	€ 121,270 Profit after taxes 2023: € 121,270 ▼ 3% vs 2022 (€ 125,052) Unfavourable step	€ 92,580 Profit after taxes 2024: € 92,580 ▼ 24% vs 2023 (€ 121,270) Unfavourable step	€ 117,236 Profit after taxes 2025: € 117,236 ▲ 27% vs 2024 (€ 92,580) Favourable step	▲ 27%
Equity	€ 576,149 Equity 2022: € 576,149 First fiscal year in the series	€ 623,735 Equity 2023: € 623,735 ▲ 8% vs 2022 (€ 576,149) Favourable step	€ 647,894 Equity 2024: € 647,894 ▲ 4% vs 2023 (€ 623,735) Favourable step	€ 696,709 Equity 2025: € 696,709 ▲ 8% vs 2024 (€ 647,894) Favourable step	▲ 8%
Total debts	€ 81,396 Total debts 2022: € 81,396 First fiscal year in the series	€ 100,342 Total debts 2023: € 100,342 ▲ 23% vs 2022 (€ 81,396) Unfavourable step	€ 74,436 Total debts 2024: € 74,436 ▼ 26% vs 2023 (€ 100,342) Favourable step	€ 80,607 Total debts 2025: € 80,607 ▲ 8% vs 2024 (€ 74,436) Unfavourable step	▲ 8%
Cash	€ 306,331 Cash 2022: € 306,331 First fiscal year in the series	€ 395,864 Cash 2023: € 395,864 ▲ 29% vs 2022 (€ 306,331) Favourable step	€ 185,173 Cash 2024: € 185,173 ▼ 53% vs 2023 (€ 395,864) Unfavourable step	€ 233,535 Cash 2025: € 233,535 ▲ 26% vs 2024 (€ 185,173) Favourable step	▲ 26%
Land & buildings	-	-	€ 200,000 Land & buildings 2024: € 200,000 First fiscal year in the series	€ 200,000 Land & buildings 2025: € 200,000 Unchanged (€ 200,000) Unchanged
Retained profit	€ 557,149 Retained profit 2022: € 557,149 First fiscal year in the series	€ 604,735 Retained profit 2023: € 604,735 ▲ 9% vs 2022 (€ 557,149) Favourable step	€ 628,894 Retained profit 2024: € 628,894 ▲ 4% vs 2023 (€ 604,735) Favourable step	€ 677,709 Retained profit 2025: € 677,709 ▲ 8% vs 2024 (€ 628,894) Favourable step	▲ 8%
Dividend	€ 52,032 Dividend 2022: € 52,032 First fiscal year in the series	€ 73,684 Dividend 2023: € 73,684 ▲ 42% vs 2022 (€ 52,032) Unchanged	€ 68,421 Dividend 2024: € 68,421 ▼ 7% vs 2023 (€ 73,684) Unchanged	€ 68,421 Dividend 2025: € 68,421 Unchanged (€ 68,421) Unchanged
Bank debt	€ 13,362 Bank debt 2022: € 13,362 First fiscal year in the series	€ 13,532 Bank debt 2023: € 13,532 ▲ 1% vs 2022 (€ 13,362) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 13,532) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 657,545 Balance sheet total 2022: € 657,545 First fiscal year in the series	€ 724,077 Balance sheet total 2023: € 724,077 ▲ 10% vs 2022 (€ 657,545) Unchanged	€ 722,330 Balance sheet total 2024: € 722,330 Unchanged (€ 724,077) Unchanged	€ 777,316 Balance sheet total 2025: € 777,316 ▲ 8% vs 2024 (€ 722,330) Unchanged	▲ 8%

Key figures of DR. ANNKE NELDE - GERIATRIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. ANNKE NELDE - GERIATRIE?

What happened at DR. ANNKE NELDE - GERIATRIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 3, 2026 New annual accounts for financial year 2025: profit of € 117,236 (▲ 27% vs 2024). Source: NBB ↗
Sep 9, 2014 New establishment in Beauvechain. KBO
2014 Sven Delsupehe became a director. NBB
2014 Annke Nelde became a director. NBB
Sep 9, 2014 Start of the company according to the CBE. KBO

In short

From € 125,052 profit in 2022 to € 117,236 profit in 2025.

Paid € 194,682 in corporate taxes since 2022.

Best year ever: 2022, with € 125,052 profit.

Paid out € 262,558 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. ANNKE NELDE - GERIATRIE? We notify you, reason included.

Follow DR. ANNKE NELDE - GERIATRIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sven Delsupehe Annke Nelde

DR. ANNKE NELDE - GERIATRIE

Behind DR. ANNKE NELDE - GERIATRIE are Sven Delsupehe and Annke Nelde.

See the full network in the app

Directors

According to the 2025 annual accounts

Sven Delsupehe

Director

since 2014

Annke Nelde

Director

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Delherse,H.-M. 20

1320 Beauvechain

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0562.727.484
VAT number: BE 0562.727.484
Registered office: Rue Delherse,H.-M. 20, 1320 Beauvechain
Names & denominations: DR. ANNKE NELDE - GERIATRIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 September 2014
Peppol: Active · Active since 18 Feb 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗